Catalyst Wire Dossier Catalyst Wire Dossier

DA-6034 Eye Drops

DA-6034 · Dong-A ST Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-6034 Eye Drops, covering 2014-10-01 to 2014-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome [Phase 2]

See pricing